Keith C. Kummerfeld

Keith C. Kummerfeld discloses dealings in Arcturus Therapeutics Holdings Inc. to SEC (Form 4). Between 12 September 2019 and 14 July 2023, the trades on record add up to 10 filings.

The open-market side counts 2 purchases for €18k alongside 2 sales for €396k. Netting one side against the other leaves €378k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 6 option exercises. In 2023 alone, the filings show no purchases and 2 sales.

The record was last updated on 18 July 2023 with an option exercise (€36k) in Arcturus Therapeutics Holdings Inc. The clock since the last published purchase (12 June 2020) now reads 2,324 days. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.